The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
THE WOODLANDS, TX, March 04, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix” or the "Company”), a medical device company dedicated to advancing precision nerve-targeted ...
THE WOODLANDS, TX, March 04, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted ...
Abstract: Quick and accurate access to medical information is crucial for patients and healthcare professionals alike. Traditional search engines often fail to concise and context-specific responses ...
This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text component.
SAULTE STE MARIE — MyMichigan Medical Center Sault has begun offering PSMA PET scans, providing men in the eastern Upper Peninsula with an advanced imaging tool to detect prostate cancer. The ...
Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.
The digital transformation of healthcare has ushered in an era where data is no longer merely a record of clinical encounters, but a dynamic asset capable of driving precision medicine. This Research ...
Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, ...
Northern Arizona Healthcare will be hosting a Meet Our Experts Live event on the Flagstaff Medical Center campus Thursday focusing on prostate cancer. Matthew Greer, MD, Sarah Conlon, MD and Stephanie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results